- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07798635
SJFT Performance, Inhibitory Control, and Attention in Young Judokas
The Relationship Between Special Judo Fitness Test (SJFT) Performance and Inhibitory Control and Selective Attention in Young Judokas
This study will examine the relationship between judo-specific physical fitness and cognitive performance in young male judo athletes and will evaluate the immediate effects of the Special Judo Fitness Test (SJFT) on attention and inhibitory control. Licensed male judo athletes who train regularly at least three days per week will be compared with male participants who do not actively participate in sports.
Judo athletes will complete a standardized warm-up followed by the SJFT, a judo-specific high-intensity fitness test involving repeated throws performed over three short exercise periods separated by brief rest intervals. Heart rate will be measured immediately after the SJFT and again one minute later.
Cognitive performance will be assessed using a computerized Flanker Task, which will measure reaction time and response accuracy while participants respond to relevant visual information and ignore distracting information. Judo athletes will complete the Flanker Task approximately one minute before and one minute after the SJFT. Participants in the control group will complete the same cognitive assessment twice over a similar time interval without performing the physical exercise.
The study will aim to determine whether judo-specific physical fitness and judo experience are associated with attention and inhibitory control and whether a single high-intensity judo-specific exercise session will produce an immediate change in cognitive performance.
Aperçu de l'étude
Statut
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Türkiye
-
Istanbul, Türkiye, Turquie (Türkiye), 34342
- Boğaziçi University
-
Contact:
- Muhammed Sıddık Çemç, Dr.
- Numéro de téléphone: +90 537 016 29 25
- E-mail: mscemc@gmail.com
-
Contact:
- E-mail: mscemc@gmail.com
-
Chercheur principal:
- Muhammed Sıddık Çemç, Dr.
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
Male participants residing in Istanbul. For the judo group: licensed judo athletes who regularly participate in judo training at least three days per week.
For the control group: individuals who are not actively involved in any sports branch.
Right-handed participants, as determined using the Edinburgh Handedness Inventory.
Participants who provide informed consent to participate in the study.
Exclusion Criteria:
History of visual impairment. History of neurological disorders. History of psychiatric disorders. History of cardiovascular disease. Current medication use.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Non randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Judo Group
Participants in the judo group will complete a standardized warm-up followed by the Special Judo Fitness Test (SJFT).
Cognitive performance will be assessed using the Flanker Task approximately one minute before and one minute after the SJFT.
|
The Special Judo Fitness Test is a judo-specific high-intensity exercise test consisting of three exercise periods: 15 seconds, 30 seconds, and 30 seconds, with 10-second rest intervals between periods.
During the test, the participant will perform as many ippon-seoi-nage throws as possible using two partners positioned six meters apart.
|
|
Aucune intervention: Control Group
Participants in the control group will not perform the SJFT or any other exercise intervention.
They will complete the Flanker Task twice over a similar time interval while remaining at rest.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Flanker Task Correct Responses
Délai: Approximately 1 minute before and 1 minute after the intervention
|
Response accuracy will be assessed using a computerized Flanker Task.
The number of correct responses will be recorded separately for congruent and incongruent trials.
Higher numbers of correct responses indicate greater response accuracy.
|
Approximately 1 minute before and 1 minute after the intervention
|
|
Change in Flanker Task Reaction Time
Délai: Approximately 1 minute before and 1 minute after the intervention
|
Reaction time will be assessed for congruent and incongruent trials using a computerized Flanker Task.
Lower reaction times indicate faster cognitive responses.
|
Approximately 1 minute before and 1 minute after the intervention
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- E-84391427-050.04-297820
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .